Victor E. Ortega MD, PhD , Vickram Tejwani MD , Abhishek Kumar Shrivastav MS , Sara Pasha MD , Joe G. Zein MD, PhD , Meher Boorgula MS , Mario Castro MD, MPH , Loren Denlinger MD, PhD , Serpil C. Erzurum MD , John V. Fahy MD , Elliot Israel MD , Nizar N. Jarjour MD , Bruce Levy MD , David Mauger PhD , Wendy C. Moore MD , Sally E. Wenzel MD , Prescott Woodruff MD, MPH , Gregory A. Hawkins PhD , Eugene R. Bleecker MD , Deborah A. Meyers PhD
{"title":"α1-Antitrypsin Gene Variation Associates With Asthma Exacerbations and Related Health Care Utilization","authors":"Victor E. Ortega MD, PhD , Vickram Tejwani MD , Abhishek Kumar Shrivastav MS , Sara Pasha MD , Joe G. Zein MD, PhD , Meher Boorgula MS , Mario Castro MD, MPH , Loren Denlinger MD, PhD , Serpil C. Erzurum MD , John V. Fahy MD , Elliot Israel MD , Nizar N. Jarjour MD , Bruce Levy MD , David Mauger PhD , Wendy C. Moore MD , Sally E. Wenzel MD , Prescott Woodruff MD, MPH , Gregory A. Hawkins PhD , Eugene R. Bleecker MD , Deborah A. Meyers PhD","doi":"10.1016/j.jaip.2025.01.039","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>α<sub>1</sub>-Antitrypsin deficiency is caused by rare pathogenic variants in <em>SERPINA1</em>, the strongest genetic risk factor for chronic obstructive pulmonary disease. Few studies have evaluated the effects of <em>SERPINA1</em> variation on asthma severity accounting for critical gene-by-environment interactions with smoking.</div></div><div><h3>Objective</h3><div>To characterize the influence of <em>SERPINA1</em> variation on asthma severity.</div></div><div><h3>Methods</h3><div>DNA samples from 847 non-Hispanic White and 446 African American participants from the Severe Asthma Research Program underwent <em>SERPINA1</em> resequencing to identify rare variants. An independent population of 1955 individuals with asthma and α<sub>1</sub>-antitrypsin concentrations from a Cleveland Clinic Health System (CCHS) database were evaluated for severity measures.</div></div><div><h3>Results</h3><div>In White participants, a history of minimum smoking significantly interacted with <em>SERPINA1</em> low-to-rare frequency variation to determine risk for asthma-related health care utilization. This was attributed to protease inhibitor type Z heterozygotes (MZ, N = 11), who had a higher frequency of emergency department (ED) visits (6 [54.5%] MZ heterozygotes, odds ratio [OR] = 7.60, 95% confidence interval [CI] = 1.71-39.7, <em>P</em> = .010), hospitalization (5 [45.5%], OR = 16.1, 95% CI = 2.64-150.4, <em>P</em> = .0050) in the past year, and lifetime intensive care unit (ICU) admissions (6 [54.5%], OR = 12.5, 95% CI = 2.44-75.6, <em>P</em> = .0032) compared with 146 individuals without <em>SERPINA1</em> variants (30 [20.5%] reporting ED visits, 17 [11.6%] hospitalization, and 15 [10.3%] ICU admission). <em>SERPINA1</em> variant-by–ever smoking interactions in African American participants for ED visits (<em>P</em> = .069) were related to 4 of 6 compound heterozygotes reporting an ED visit. In CCHS, α<sub>1</sub>-antitrypsin concentrations were inversely associated with moderate-to-severe asthma risk (OR = 0.97 per 10 mg/dL increase in α<sub>1</sub>-antitrypsin, 95% CI = 0.94-0.99, <em>P</em> = .010) and exacerbations (OR = 0.84 per 10 mg/dL, 95% CI = 0.76-0.94, <em>P</em> = .002).</div></div><div><h3>Conclusions</h3><div><em>SERPINA1</em> variation and α<sub>1</sub>-antitrypsin concentrations impact asthma severity through gene-environment interactions with minimum smoking.</div></div>","PeriodicalId":51323,"journal":{"name":"Journal of Allergy and Clinical Immunology-In Practice","volume":"13 7","pages":"Pages 1634-1646.e7"},"PeriodicalIF":6.6000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Allergy and Clinical Immunology-In Practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213219825001643","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/13 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
α1-Antitrypsin deficiency is caused by rare pathogenic variants in SERPINA1, the strongest genetic risk factor for chronic obstructive pulmonary disease. Few studies have evaluated the effects of SERPINA1 variation on asthma severity accounting for critical gene-by-environment interactions with smoking.
Objective
To characterize the influence of SERPINA1 variation on asthma severity.
Methods
DNA samples from 847 non-Hispanic White and 446 African American participants from the Severe Asthma Research Program underwent SERPINA1 resequencing to identify rare variants. An independent population of 1955 individuals with asthma and α1-antitrypsin concentrations from a Cleveland Clinic Health System (CCHS) database were evaluated for severity measures.
Results
In White participants, a history of minimum smoking significantly interacted with SERPINA1 low-to-rare frequency variation to determine risk for asthma-related health care utilization. This was attributed to protease inhibitor type Z heterozygotes (MZ, N = 11), who had a higher frequency of emergency department (ED) visits (6 [54.5%] MZ heterozygotes, odds ratio [OR] = 7.60, 95% confidence interval [CI] = 1.71-39.7, P = .010), hospitalization (5 [45.5%], OR = 16.1, 95% CI = 2.64-150.4, P = .0050) in the past year, and lifetime intensive care unit (ICU) admissions (6 [54.5%], OR = 12.5, 95% CI = 2.44-75.6, P = .0032) compared with 146 individuals without SERPINA1 variants (30 [20.5%] reporting ED visits, 17 [11.6%] hospitalization, and 15 [10.3%] ICU admission). SERPINA1 variant-by–ever smoking interactions in African American participants for ED visits (P = .069) were related to 4 of 6 compound heterozygotes reporting an ED visit. In CCHS, α1-antitrypsin concentrations were inversely associated with moderate-to-severe asthma risk (OR = 0.97 per 10 mg/dL increase in α1-antitrypsin, 95% CI = 0.94-0.99, P = .010) and exacerbations (OR = 0.84 per 10 mg/dL, 95% CI = 0.76-0.94, P = .002).
Conclusions
SERPINA1 variation and α1-antitrypsin concentrations impact asthma severity through gene-environment interactions with minimum smoking.
期刊介绍：
JACI: In Practice is an official publication of the American Academy of Allergy, Asthma & Immunology (AAAAI). It is a companion title to The Journal of Allergy and Clinical Immunology, and it aims to provide timely clinical papers, case reports, and management recommendations to clinical allergists and other physicians dealing with allergic and immunologic diseases in their practice. The mission of JACI: In Practice is to offer valid and impactful information that supports evidence-based clinical decisions in the diagnosis and management of asthma, allergies, immunologic conditions, and related diseases.
This journal publishes articles on various conditions treated by allergist-immunologists, including food allergy, respiratory disorders (such as asthma, rhinitis, nasal polyps, sinusitis, cough, ABPA, and hypersensitivity pneumonitis), drug allergy, insect sting allergy, anaphylaxis, dermatologic disorders (such as atopic dermatitis, contact dermatitis, urticaria, angioedema, and HAE), immunodeficiency, autoinflammatory syndromes, eosinophilic disorders, and mast cell disorders.
The focus of the journal is on providing cutting-edge clinical information that practitioners can use in their everyday practice or to acquire new knowledge and skills for the benefit of their patients. However, mechanistic or translational studies without immediate or near future clinical relevance, as well as animal studies, are not within the scope of the journal.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
